References
- XavierRJPodolskyDKUnraveling the pathogenesis of inflammatory bowl diseaseNature2007448715242743417653185
- ShiDDasJDasGInflammatory bowel disease requires the interplay between innate and adaptive immune signalsCell Res2006161707416467877
- FussIJHellerFBoirivantMNonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitisJ Clin Invest2004113101490149715146247
- LakatosLImmunology of inflammatory bowel diseasesActa Physiol Hung200087435537211732889
- TsukadaYNakamuraTIimuraMCytokine profile in colonic mucosa of ulcerative colitis correlates with diseases activity and response to granulocytopharesisAm J Gastroenterol200297112820282812425554
- MurchSHLamkinVASavageMOSerum concentrations of tumor necrosis factor alpha in childhood chronic inflammatory bowel diseaseGut19913289139171885073
- MurchSHBraeggerCPWalker-SmithJAMacDonaldTTLocation of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel diseaseGut19933412170517098031350
- BraeggerCPNichollsSMurchSHTumor necrosis factor alpha in stool as a marker of intestinal inflammationLancet1992339878589911345871
- ProbertCSHearingSDSchreiberSInfliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomized controlled trialGut2003527998100212801957
- JakobovitsSLJewellDPTravisSPLInfliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006Aliment Pharmcol Ther200725910551060
- SandsBETremaineWJSandbornWJInfliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyInflamm Bowel Dis200172838811383595
- OschenskuhnTSackmannMGokeBInfliximab for acute, not steroid refractory ulcerative colitis: a randomized pilot studyEur J Gastroenterol Hepatol200416111167117115489577
- GisbertJPGonzalez-LamaYMateJSystematic review: infliximab therapy in ulcerative colitisAliment Pharmacol Ther2006251193717229218
- HanauerSBFeaganBFLichtensteinGRMaintenance infliximab for Crohn’s disease: the ACCENT I randomized trialLancet200235993171541154912047962
- SandsBEAndersonFHBernsteinCNInfliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med2004350987688514985485
- RutgeertsPSandbornWJFeaganBFInfliximab for induction and maintenance therapy for ulcerative colitisN Engl J Med2005353232462247616339095
- Lennard-JonesJEClassification of inflammatory bowel diseaseScand J Gastroenterol Suppl1989170262617184
- RudolphSJWeinbergDLMcCabeRPLong-term durability of Crohn’s disease treatment with infliximabDig Dis Sci20085341033104117934827
- LichtensteinGRDiamondRHWagnerAInfliximab administration as a 3-dose induction followed by scheduled maintenance therapy in IBD: comparable clinical outcomes with or without concomitant immunomodulatorsGastroenterology20071325A146
- FeaganBMcDonaldJWPanaccioneRA randomized trial of methotrexate in combination with infliximab for the treatment of Crohn’s diseaseGastroenterology20081351294295
- ColombelJFSandbornWJReinishHInfliximab, azathioprine or combination therapy for Crohn’s diseaseN Engl J Med2010362151383139520393175
- SchnitzlerFFidderHFerranteMLong-term outcome of treatment with infliximab in 614 Crohn’s disease patients: results from a single centre cohortGut200958449250018832518
- SandsBEBlankMAPatelKvan DeventerSJLong-term treatmnet of rectovaginal fistulas in Crohn’s disease: response to infliximab in the ACCENT II studyClin Gastroenterol Hepatol200421091292015476155
- RutgeertsPFeaganBGLichtensteinGRComparison of scheduled and episodic treatment strategies of infliximab in Crohn’s diseaseGastroenterology2004126240241314762776
- JarnerotGHertervigEFriis-LibyIInfliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled studyGastroenterology200512871805181115940615
- LeesCDHeysDHoGTA retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisAliment Pharmacol Ther200726341141917635376
- CaspersenSElkjaerMRiisLInfliximab for inflammatory bowel disease in Denmark 1999–2005: Clinical outcome and follow-up evaluation of malignancy and mortalityClin Gastroenterol Hepatol20086111212121718848503
- PoupardinCLemannMGendreJPEfficacy of infliximab in Crohn’s disease. Result of a retrospective multicenter study with a 15-month follow-upGastroenterol Clin Biol200630224725216565658
- TeshimaCWThompsonADhanoaLLong- term response rates to infliximab therapy for Crohn’s disease in an outpatient cohortCan J Gastroenterol200923534835219440565
- FerranteMVermeireSKonstantinatosHPredictors of early response to infliximab in patients with ulcerative colitisInflamm Bowel Dis200713212312817206703
- StocchiLPembertonJHPouch and pouchitisGastroenterol Clin North Am200130122324111394032
- ViscidoAHabibFIKohnAInfliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitisAliment Phamacol Ther2003171012631271